Research & Development
COVID-19: Page 2
University of Michigan breath analysis technology holds potential for COVID-19 detection
A diagnostic study indicates that a portable breath-based volatile organic compound monitor may have potential for COVID-19 detection.
March 1, 2023
Mologic receives FDA EUA for at-home SARS-CoV-2 antigen test, eyes additional respiratory diseases
The development of the rapid antigen test was funded under an $11.8 million contract through the US National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative.
February 27, 2023
FDA authorizes Lucira Health OTC test, the first to detect influenza and COVID-19 viruses
In people with symptoms, the Lucira COVID-19 & Flu Test correctly identified 99.3% of negative and 90.1% of positive influenza A samples; 100% of negative and 88.3% of positive COVID-19 samples; and 99.9% of negative influenza B samples, the FDA said.
February 24, 2023
Heart problems more likely among long COVID patients in comprehensive study
In the study, investigators found that individuals who experienced long COVID had more than double the risk of developing new cardiovascular symptoms.
February 23, 2023
Co-Diagnostics commences clinical evaluations for at-home platform, initial COVID-19 test
Co-Diagnostics added that it is developing a real-time PCR platform for the detection of infectious diseases in at-home and point-of-care settings.
February 22, 2023
Meta-analysis reveals roadmap for effective use of convalescent plasma in pandemics
A meta-analysis has linked the administration of convalescent plasma to a reduced rate of hospitalization for COVID-19, revealing a roadmap for future use.
February 21, 2023
Quest launches long-COVID testing panels for consumers
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
COVID-19 infection provides natural immunity, at least for a while: Lancet study
A comprehensive study provides evidence about the extent of natural immunity protection by COVID-19 variants, and how this protection fades over time.
February 17, 2023
Labcorp Q4 revenues drop 10% despite base business growth
The firm booked $1.1 billion in 2022 revenue for COVID-19 testing, but it expects such revenue to drop by 75% to 90% in 2023.
February 16, 2023
Cedars Sinai researchers find that COVID-19 infection increases diabetes risk
In a study, the researchers found that people who have had COVID-19 are at increased risk for new-onset diabetes type 2 diabetes; vaccination prior to infection may reduce this risk.
February 14, 2023
Computer program may enable padlock probes that quickly detect emerging variants
Researchers at the Indian Institute of Technology Madras set out to develop a tool that could not only design padlock probes automatically, but also systematically consider all the necessary technical parameters at once to make the process easier.
February 15, 2023
Many long-COVID patients show organ damage one year later: Study
A comprehensive study shows organ damage persisted in 59% of long-COVID patients a year after infection, even in those not initially severely affected.
February 15, 2023
Lingering symptoms common after COVID hospitalization: NIH-supported study
After six months, more than seven in 10 adults surveyed experienced cardiopulmonary problems, such as coughing, rapid or irregular heartbeat, and breathlessness, while about half had fatigue or physical limitations.
February 14, 2023
Page 2 of 29